1. Home
  2. TECX vs CLB Comparison

TECX vs CLB Comparison

Compare TECX & CLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$28.61

Market Cap

618.9M

Sector

N/A

ML Signal

N/A

Logo Core Laboratories Inc.

CLB

Core Laboratories Inc.

N/A

Current Price

$12.12

Market Cap

573.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
CLB
Founded
2019
1936
Country
United States
United States
Employees
N/A
3300
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
618.9M
573.6M
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
TECX
CLB
Price
$28.61
$12.12
Analyst Decision
Strong Buy
Hold
Analyst Count
5
2
Target Price
$75.20
$12.50
AVG Volume (30 Days)
197.5K
378.1K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
0.23%
EPS Growth
40.70
N/A
EPS
N/A
0.11
Revenue
N/A
$526,520,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.75
P/E Ratio
N/A
$111.45
Revenue Growth
N/A
0.51
52 Week Low
$14.39
$9.79
52 Week High
$39.53
$20.36

Technical Indicators

Market Signals
Indicator
TECX
CLB
Relative Strength Index (RSI) 39.61 50.50
Support Level $27.53 $11.62
Resistance Level $31.39 $12.27
Average True Range (ATR) 2.27 0.45
MACD -0.57 -0.05
Stochastic Oscillator 5.14 53.34

Price Performance

Historical Comparison
TECX
CLB

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About CLB Core Laboratories Inc.

Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.

Share on Social Networks: